Neurocrine Biosciences, Inc. Announces Conference Call And Webcast To Present Third Quarter 2006 Financial Results
SAN DIEGO, Oct. 11 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. announced today that the Company will report its third quarter 2006 financial results after the Nasdaq market closes on Thursday, November 2, 2006. A live conference call and webcast will be held at 5:00 p.m. Eastern Standard Time (2:00 p.m. Pacific Standard Time).
Participants can access the live conference call by dialing 1-800-903-0258 (US) or 785-832-0326 (International) using the conference ID# 7NBIX. The call can also be accessed via the webcast through the Company's website at http://www.neurocrine.com
If you are unable to attend the Webcast and would like further information on this announcement please contact Claudia Woodworth or Elizabeth Foster in the Investor Relations Department at Neurocrine Biosciences at (858) 617-7600. A replay of the Conference Call will be available approximately one hour after the conclusion of the call by dialing 1-800-695-0974 (US) or 402-220-1459 (International). The call will be archived for two weeks.
Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. The product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, irritable bowel syndrome, and CNS related disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the Internet at http://www.neurocrine.comNeurocrine Biosciences, Inc.
CONTACT: Claudia Woodworth or Elizabeth Foster, both of NeurocrineBiosciences, +1-858-617-7600
Web site: http://www.neurocrine.com/